References
- Richardson E. Progressive multifocal leukoencephalopathy. N Engl J Med 1961; 265: 815–23
- Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984; 2: 299–313
- Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 1991; 41: 1733–6
- Tyler KL. The uninvited guest: JC virus infection of neurons in PML. Neurology 2003; 61: 734–5
- Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. Two-and-half y remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 1997; 349: 850
- Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999; 52: 623–5
- Tantisiriwat W, Tebas P, Clifford D, Powderly W, Fichtenbaum CJ. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Inf Dis 1999; 28: 1152–4
- Safdar A, Rubocki R, Horvath J, Narayan K, Waldron R. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Inf Dis 2002; 35: 1250–7
- Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005; 109: 449–55
- Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA, Letvin NL, Japour AJ. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252–5
- Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157–61
- Karavellas MP, Lowder CY, Macdonald C, Avila CP, Jr, Freeman WR. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998; 116: 169–75
- Woo H, Rezai A, Knopp E, Weiner H, Miller D, Kelly P. Contrast-enhancing progressive multifocal leukoencephalopathy: Radiological and pathological correlations: case report. Neurosurgery 1996; 39: 1031–5
- Collazos J, Mayo J, Martinez E, Blanco M. Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 1999; 13: 1426–8
- Cinque P, Pierotti C, Vigano M, Bestetti A, Fausti C, Bertelli D, Lazzarin A. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J NeuroVirol 2001; 7: 358–63
- Berger J, Levy R, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998; 44: 341–9
- Koralnik I, Du Pasquier R, Letvin N. JC virus-specific cytotoxic T-lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 2001; 75: 3483–7
- Gasnault J, Kahraman M, Ghislaine de Goerde Herve, Durali D, Delfraissy J, Taoufik Y. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 2003; 17: 1443–9
- Agostini HT, Ryschkewitsch CF, Stoner GL. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 1996; 34: 159–64
- Ault GS., Stoner GL. Human polyomavirus JC promoter enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J General Virology 1993; 74: 1499–1507